Additive effect of latanoprost and dorzolamide in patients with elevated intraocular pressure

International Ophthalmology

Volumn 22, Issue 1, 1998, Pages 37-42

  Arici, Mustafa Kemal ^a   Topalkara, Ayşen ^a   Güler, Cenap ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Additive effect; Dorzolamide; Intraocular pressure; Latanoprost

Indexed keywords

ANTIGLAUCOMA AGENT; CARBONATE DEHYDRATASE INHIBITOR; DORZOLAMIDE; LATANOPROST; PROSTAGLANDIN F2 ALPHA DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CROSSOVER PROCEDURE; DRUG EFFECT; DRUG POTENTIATION; FEMALE; GLAUCOMA; HUMAN; HYPEREMIA; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE ABNORMALITY; MALE; OPEN ANGLE GLAUCOMA; TREATMENT OUTCOME;

ADULT; CARBONIC ANHYDRASE INHIBITORS; CROSS-OVER STUDIES; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; EXFOLIATION SYNDROME; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; PROSTAGLANDINS F, SYNTHETIC; SINGLE-BLIND METHOD; SULFONAMIDES; THIOPHENES; TREATMENT OUTCOME;

EID: 0032419372     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006176713983     Document Type: Article

References (31)

1. 2α on aqueous humor dynamics in cynomogus monkeys. Curr Eye Res 1987; 6: 1035-1044.
2. 2α on trabecular outflow facility in cynomolgus monkeys. Exp Eye Res 1990; 51: 87-91.
3. 2α, A2, and their esters in glaucomatous monkey eyes. Invest Ophthalmol Vis Sci 1990; 31: 2466-2470.
4. Bito LZ, Camras CB, Gum GG, Resul B. The ocular hypotensive effects and side effects of prostaglandins on the eyes of experimental animals. Prog Clin Biol Res 1989; 312: 349-368.
5. Hoyng PF, Groeneboer MC. The effects of prostacyclin and its stable analog on intraocular pressure. Prog Clin Biol Reg 1989; 312: 369-378.
6. 2α-1-isopropylester lowers intraocular pressure without decreasing aqueous humor flow. Am J Ophthalmol 1988; 105: 30-34.
7. 2α-isopropylester eye drops: Effect in normal human eyes. Br J Ophthalmol 1989; 73: 419-426.
8. 2α-1-isopropyl ester applied in multiple doses in ocular hypertensive and glaucoma patients. Opthalmology 1989; 96:1329-1336.
9. Guiffre G. The effects of prostaglandin F2 in the human eye. Graefes Arch Clin Exp Ophthalmol 1985; 222:139-141.
10. Alm A, Villumsen J. PhXA34, a new potent ocular hypotensive drug. A study on dose-response relationship and on aqueous humor dynamics in healthy volunteers. Arch Ophthalmol 1991; 109:1564-1568.
11. 2α analogue. Effect on intraocular pressure in with ocular hypertension. Br J Ophthalmol 1992; 762 214-217.
12. Alm A, Villumsen J, Törnquist P., Mandahl A, Airaksinen J, Tuulonen A, Marks A, Resul B, Stjerschantz J. Intraocular pressure-reducing effect of PhXA41 in patients with increased eye pressure. A one-month study. Ophthalmology 1993; 100: 1312-1317.
13. Mishima HK, Masuda K, Kitazava Y, Azuma I, Araie M. A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. Arch Ophthalmol 1996; 114:929-932.
14. 2α analogue (PhXa41). An in-hospital, placebo-controlled study. Arch Ophthalmol 1993; 111: 657-661.
15. 2α analogue after topical application in normal and ocular hypertensive human eyes. Arch Opthalmol 1993; 111: 1351-1358.
16. Alm A, Stjernschantz J, The Scandinavian Latanoprost Study Group. Effects of intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning a comparison with timolol. Ophthalmology 1995; 102: 1743-1752.
17. 2α analogue, on aqueous dynamics in human eyes. Ophthalmology 1993; 100: 1297-304.
18. Alm A, Widengard I, Kjellen D, Söderström M, Friström B, Heijil A, Stjerschantz J. Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol. Br J Ophthalmol 1995; 79: 12-16.
19. Nagasubramanian S, Sheth GP, Hitchings RA, Stjernschantz, J. Intraocular pressure-reducing effect of PhXA41 in ocular hypertension, comparison of dose regimens. Ophthalmology 1993 100: 1305-1311.
20. Camras CB, The United States Latanoprost Study Group. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma. Ophthalmology 1996; 103: 138-147.
21. 2α-isopropylester to timolol in patients with open angle glaucoma. Arch Ophthalmol 1990; 108: 1102-1105.
22. 2α-isopropylester to timolol in glaucoma patients. Ophthalmology 1991; 98: 1079-1082.
23. Laibovitz R, Strahlman ER, Barber BL, Strohmaier KM. Comparison of quality of life and patient preference of dorzolamide and pilocarpine as adjunctive therapy to timolol in the treatment of glaucoma. Journal of Glaucoma 1995; 4: 306-313.
24. Strahlman ER, Vogel R, Tipping R, Clineschmidt CM, BA, The Dorzolamide Additivity Study Group. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. Ophthalmology 1996; 103: 1283-1293.
25. Rulo AH, Greve EL, Hoyng PF. Additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure. Ophthalmology 1997; T04: 1503-1507.
26. Lippa EA, Schuman JS, Higginbotham EJ, Kass MA, Weinreb RN, Skuta GL, Epstein DL, Shaw B, Holder DJ, Deasy DA, Wilensky JT. MK-507 versus sezolamide. Comparative efficacy of two topical active carbonic anhydrase inhibitors. Ophthalmology 1991; 98: 308-313.
27. Lippa EA, Carlson LE, Ehinger B, Eriksson LO, Finnström K, Holmin C, Nilsson SE, Nyman K, Raitta C, Ringvold A, Tarkkanen A, Vegge T, Deasy D, Holder D, Ytteborg J. Dode. Response and duration of dorzolamide, a topical carbonic anhydrase inhibitor. Arch Ophthalmol 1992; 110: 495-499.
28. Wilkerson M, Cyrlin M, Lippa EA, Esposito D, Deasy D, Panebianco D, Fazio R, Yablonski M, Shields B. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor. Arch Ophthalmol 1993, 111: 1343-1350.
29. Strahlman E, Tipping R, Vogel R, and International Dorzolamide Study group. A double-masked, randomized 1 year study comparing dorzolamide (Trusopt), timolol, and betaxolol. Arch Ophthalmol 1995; 113: 1009-1016.
30. 2α analogue, and timolol in patients with elevated intraocular pressure. Br J Ophthalmol 1994; 78: 899-902.
31. Friström B, Nilson SEG. Interaction of PhXA41 a new prostaglandin analogue with pilocarpine. A study on patients with elevated intraocular pressure. Arch Ophthalmol 1993; 111: 662-665.